Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)

Conditions:   Chronic Diarrhea;   Irritable Bowel Syndrome With Diarrhea;   Bile Acid Malabsorption;   Bile Acid Diarrhea;   Bile Acid Malabsorption Syndrome Type II Interventions:   Drug: Aldafermin;   Drug: Placebo Sponsors:   Michael Camilleri, MD;   NGM Biopharmaceuticals, Inc Not yet recruiting

Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials